Evaluation of clinical efficacy of COVID-19 vaccination in patients with hematological diseases.
Latest Information Update: 24 Jan 2023
At a glance
- Drugs Tozinameran (Primary)
- Indications COVID 2019 infections
- Focus Therapeutic Use
Most Recent Events
- 24 Jan 2023 New trial record
- 13 Dec 2022 Results (n=58) assessing the antibody titers of COVID-19 in patients with myeloid malignancies who received a third mRNA-based COVID-19 vaccine dose (booster), presented at the 64th American Society of Hematology Annual Meeting and Exposition.